Neonatal Glucose Screening Evaluation and Treatment: Difference between revisions
From Guide to YKHC Medical Practices
No edit summary |
|||
| Line 1: | Line 1: | ||
===Resources/References=== | ===Resources/References=== | ||
Latest revision as of 08:33, 4 November 2021
Resources/References
- Harris, et al. Dextrose gel for neonatal hypoglycaemia (the Sugar Babies Study): a randomised, double-blind, placebo-controlled trial. The Lancet. Volume 382, Issue 9910, 21 December 2013–3 January 2014, Pages 2077-2083. DOI:doi.org/10.1016/S0140-6736(13)61645-1
- Committee on Fetus and Newborn. Postnatal Glucose Homeostasis in Late-Preterm and Term Infants. Pediatrics Mar 2011, 127 (3) 575-579; DOI: 10.1542/peds.2010-3851
- Wight NE; Academy of Breastfeeding Medicine. ABM Clinical Protocol #1: Guidelines for Glucose Monitoring and Treatment of Hypoglycemia in Term and Late Preterm Neonates, Revised 2021. Breastfeed Med. 2021 May;16(5):353-365. doi: 10.1089/bfm.2021.29178.new. Epub 2021 Apr 7. PMID: 33835840.
- Narvey MR, Marks SD. The screening and management of newborns at risk for low blood glucose. Paediatr Child Health. 2019 Dec;24(8):536-554. doi: 10.1093/pch/pxz134. Epub 2019 Dec 9. PMID: 31844395; PMCID: PMC6901164.
- Neonatal Glucose Screening YKHC Clinical Guideline
- Neonatal Hypoglycemia ANMC Clinical Guideline
